KWF grant together with Amsterdam UMC, NKI and UvA
We are happy to announce that Ellogon.AI has received a KWF grant together with the Amsterdam UMC, Netherlands Cancer Institute and University of Amsterdam. The research project will focus on the selection of gastric and esophageal cancer (GEC) patients for immunotherapy. With use of Artificial Intelligence, we will quantify well-known biomarkers and search for novel biomarkers which are characteristic for tumor-immune interactions, and analyse their spatial distribution and interdependance. In this way, new biomarker patterns can be identified that may predict successful immunotherapy treatment. The AI algorithms will be integrated in the clinical workflow during a pilot study and results will be correlated to immunotherapy response. An overview of the workflow of this project is shown in the figure below.
EIDOS runs on UbiOps29 December 2022
EIDOS runs on UbiOps 29 December 2022 Jessica Hot off the press! Working with the Netherlands Cancer Institute, Ellogon.AI has developed a faster and more efficient method of…
European Network of AI Excellence Centres (ELISE) 1st open call8 August 2022
Interview of co-founder Efstratios Gavves by ELISE
WeakSTIL: Weak whole-slide image level stromal tumor infiltrating lymphocyte scores are all you need4 April 2022
Scientific publication by Yoni Schirris, PhD student of the HISTO-AI project.